News
Israeli cell-based meat company, Meat-Tech 3D, is a relative newcomer to the industry but is making up for lost time with a flurry of activity. Most recently, the company filed its paperwork with the U.S. Securities and Exchange Commission to begin the process of an initial public offering.
While the paperwork is filed, the company has not finalized the price nor the number of shares. The SEC is currently reviewing the company’s registration. Meat-Tech 3D is already traded publicly on the Tel Aviv Stock Exchange, and it is the only cell-based meat company listed. When it appears on the Nasdaq, it will also be the first cell-based meat company to be traded publicly in the U.S.

A week after the company filed its paperwork for an IPO, it announced that it raised $7 million in a funding round led by Psagot. The company said it will use the funds to work toward the full acquisition of the cultured fat product developer Peace of Meat, an R&D facility which it plans to fully acquire for $17.5 million
Despite the popularity of cell-based meat as an idea, there have yet to be substantial quantities of lab-made protein available to the public. Due to continued regulatory hurdles from the U.S. Department of Agriculture and the Food and Drug Administration as well as the high price of producing meat in a lab, cell-based meat produced on an industrial scale remains a goal rather than a reality.
However, there are plenty of companies, including Memphis Meats, Finless Foods, Aleph Farms, Mosa Meat and Hampton Creek, working toward that goal. Still, manufacturer and investor enthusiasm does not always reflect consumer demand. A poll conducted last year by the marketing firm Charleston|Orwig revealed that four in 10 U.S. consumers found cell-based meat production to be “scary.” Without consumer support to generate demand for these products, it is unlikely that they will become widespread in retail and foodservice, even if these companies are traded publicly.
Nevertheless, recent IPOs like Beyond Meat have shown that companies do not necessarily need to generate profits and can even operate at a loss and still have a successful IPO.
Meat-Tech 3D’s filing is not the only move the company has made recently. The company recently succeeded in printing thin slices of “carpaccio” beef and plans to work up to a quarter-pound patty in 2021. Food Dive also reported that the company is reaching into other segments, including creating cell-based fish lines under a subsidiary known as Labofish and is working on establishing a protein factory with a focus on producing protein from plant-based cells.
Set Ingredients Network as a 'Preferred Source' to get quicker access to the news you value.
1 Oct 2026
PerfectaGEL® can cut vegan gummy drying from 36-72 hours to as little as three, depending on the application. Here is the technology behind it.
Read more
30 Sep 2026
Zero-sugar, functional, and indulgent sodas are redefining what a carbonated soft drink can offer in today’s evolving market.
Read more
29 Sep 2026
Premium ready meal innovation – with high-end meals retailing for £10 (around €12) – is heating up in the UK. What are the stand-out attributes for a winning product?
Read more
28 Sep 2026
Startup accelerator programme Breakout Wellness UK is partnering with retail major Holland & Barrett to propel eleven extraordinary startups into growth.
Read more
24 Sep 2026
The functional ingredient creatine is gaining traction in the food and drink industry, as brands ramp up production investment and explore new applications.
Read more
22 Sep 2026
Public health campaigners are celebrating the US government’s move to close the Generally Recognised as Safe (GRAS) loophole, but companies worry it will stifle innovation.
Read more
21 Sep 2026
The Food and Agriculture Organization (FAO) is promoting industrial aquaculture but campaigners say it creates toxic pollution and threatens food sovereignty.
Read more
17 Sep 2026
Nutraceuticals continue to gain ground across the Middle East and Africa with vitamins, probiotics, and functional drinks doing particularly well, says Euromonitor.
Read more
14 Sep 2026
Nestlé is to sell its mainstream vitamin, mineral, and supplement (VMS) business for $1 billion – a logical move away from “the unprofitable middle” of this category, say experts.
Read more
10 Sep 2026
Will the US dietary guidelines change the way Americans eat, swapping ultra-processed foods for whole foods? We asked Dr Barry Popkin, renowned nutrition and obesity researcher.
Read more